SPL Medical to collaborate with NanoEcho

2022 10 04 16 41 3847 Nanoparticle Blood 400

SPL Medical and NanoEcho plan to collaborate on developing the iron-based nanoparticle Ferrotran (ferumoxtran-10) for the detection of lymph node metastases on ultrasound.

The two firms have signed a letter of intent that SPL Medical will supply NanoEcho with Ferrotran, which the latter will then develop for market approval for detecting lymph node metastases in rectal cancer patients. Currently, Ferrotran is currently used mainly with MRI, the companies said.

Page 1 of 1240
Next Page